High-Tech Surgical Tools Hold Promise Despite Complexity – Circulation
This article was originally published in The Gray Sheet
Executive SummaryThe surgical community's interest in minimally invasive coronary procedures will continue to provide medical device companies with a wealth of opportunities to develop new, innovative products, according to a leading cardiac surgeon
You may also be interested in...
Oncology R&D isn’t waning, but investment in neurology and psychiatry drug development are paying off in new drug approvals. Rapid growth in CDER non-malignant hematology approvals reflects longer, broader trend toward orphan drugs.